Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-06-040372
Filing Date
2006-09-29
Accepted
2006-09-29 14:59:17
Documents
10
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 v053565_20f.htm 20-F 3658375
2 v053565_ex4-7.htm EX-4.7 289592
3 v053565_ex4-17.htm EX-4.17 88624
4 GRAPHIC chart.jpg GRAPHIC 28032
5 v053565_ex8-1.htm EX-8.1 3537
6 v053565_ex12-1.htm EX-12.1 13380
7 v053565_ex12-2.htm EX-12.2 13253
8 v053565_ex13-1.htm EX-13.1 6512
9 v053565_ex13-2.htm EX-13.2 6196
10 v053565_ex15-1.htm EX-15.1 5551
  Complete submission text file 0001144204-06-040372.txt   4125086
Mailing Address
Business Address LEVEL 1 100 DORCAS STREET SOUTH MELBOURNE VIC 3205 AUSTRALIA VICTORIA C3 00000 01161396908537
PRANA BIOTECHNOLOGY LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-49843 | Film No.: 061116956
SIC: 2834 Pharmaceutical Preparations